HIDEFRA Trademark

Trademark Overview


On Friday, January 4, 2019, a trademark application was filed for HIDEFRA with the United States Patent and Trademark Office. The USPTO has given the HIDEFRA trademark a serial number of 79252373. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, October 21, 2022. This trademark is owned by NOVARTIS AG. The HIDEFRA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
hidefra

General Information


Serial Number79252373
Word MarkHIDEFRA
Filing DateFriday, January 4, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, October 21, 2022
Registration Number5796637
Registration DateTuesday, July 9, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, October 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, January 22, 2024CHANGE OF OWNER RECEIVED FROM IB
Sunday, November 6, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, November 6, 2022DEATH OF INTERNATIONAL REGISTRATION
Thursday, September 12, 2019NOTIFICATION PROCESSED BY IB
Wednesday, August 28, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 28, 2019FINAL DISPOSITION PROCESSED
Thursday, August 8, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 9, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTICE OF PUBLICATION
Tuesday, March 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 10, 2019ASSIGNED TO EXAMINER
Saturday, March 9, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 27, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB